| 
			
			 The case involving a nearly $90 million black market vaccine ring 
			has ignited public ire and underscored regulatory weaknesses. 
 Police have detained 37 people in the northern province of Shandong, 
			which is at the heart of the scandal that was exposed over the last 
			week.
 
 The vaccines, including ones against meningitis, rabies and other 
			illnesses, are suspected of being sold in dozens of provinces around 
			China since 2011.
 
 The government has said the vaccines themselves were real, though 
			traded illegally.
 
 The scandal has stirred angry debate, casting a shadow over 
			government ambitions to bolster the domestic drug industry and 
			underlining the challenge it faces to regulate a widespread and 
			fragmented medicine supply chain.
 
 The case has centered on a mother, surnamed Pang, and her daughter 
			illegally selling vaccines to re-sellers around the country.
 
			
			 
			Li Guoqing, head of the food and drug watchdog's drug supervision 
			department, told a news conference that Pang had previously been 
			given a suspended jail sentence for a similar crime.
 "During the period of the suspended sentence, this criminal evaded 
			supervision and control and continued to engage in the criminal act 
			of illegally selling vaccines," he said, in comments streamed on a 
			government website.
 
 Li admitted there were "certain loopholes in our regulatory work" 
			that allowed the vaccines to circulate on the Chinese market for so 
			long before being found, but said there were simply not enough 
			people for the job.
 
 "At present our country has 12,000 drug wholesalers, 5,000 
			production firms and more than 400,000 drug retailers. Regulatory 
			targets are many, but there are few people on the ground, making 
			regulation difficult," Li said.
 
			
            [to top of second column] | 
 
			"There aren't even 500 people with the aptitude to inspect drugs. 
			There are dead spaces and blind zones for regulation and 
			inspection." 
			The issue of regulation, from food and drugs to online sales, has 
			become increasingly contentious in China as it looks to cast off a 
			reputation for poor quality and safety.
 The case has drawn ire from Premier Li Keqiang, who said regulatory 
			bodies, including the health ministry and police, needed to work 
			more in tandem, and that "dereliction of duty" would not be 
			tolerated.
 
 Some people have seen an echo of a 2008 scandal when milk tainted 
			with the industrial chemical melamine led to the deaths of six 
			infants and made thousands sick.
 
 The government says it has not found any spike in abnormal reactions 
			to inoculations.
 
 (Reporting by Ben Blanchard; Editing by Robert Birsel)
 
			[© 2016 Thomson Reuters. All rights 
				reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			 |